Drug Plan Management, Prescription Drugs Canadian Insurer details on coverage for Wegovy for cardiovascular treatment February 1, 2025 GroupForce Benefit News January 2025 Tags: Canada, Cardiovascular indication, Insurance, semaglutide, Wegovy, weight loss What do you think? Show comments / Leave a comment Insights More Related Articles Media 2025 Canadian Leadership Council on Drug Plan Partnerships Advise, The Workplace e2r Blog Post Alerts – Sick Notes Media The Benefits Alliance welcomes Human Capital Benefits as a Member FIrm